Page last updated: 2024-10-31

nevirapine and Hyperprolactinemia

nevirapine has been researched along with Hyperprolactinemia in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duval, X1
Larger, E1
Longuet, P1
Leport, C1
Vilde, JL1

Other Studies

1 other study available for nevirapine and Hyperprolactinemia

ArticleYear
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
    Lancet (London, England), 2001, Feb-10, Volume: 357, Issue:9254

    Topics: Adult; Drug Therapy, Combination; Female; Galactorrhea; HIV Infections; HIV Protease Inhibitors; HIV

2001